regenerative medicine | Britannica.com
Posted: June 30, 2015 at 9:42 pm
regenerative medicine,cartilage: bronchus repair using bioartificial tissue transplantationHospital Clinic of Barcelona/APthe application of treatments developed to replace tissues damaged by injury or disease. These treatments may involve the use of biochemical techniques to induce tissue regeneration directly at the site of damage or the use of transplantation techniques employing differentiated cells or stem cells, either alone or as part of a bioartificial tissue. Bioartificial tissues are made by seeding cells onto natural or biomimetic scaffolds (see tissue engineering). Natural scaffolds are the total extracellular matrixes (ECMs) of decellularized tissues or organs. In contrast, biomimetic scaffolds may be composed of natural materials, such as collagen or proteoglycans (proteins with long chains of carbohydrate), or built from artificial materials, such as metals, ceramics, or polyester polymers. Cells used for transplants and bioartificial tissues are almost always autogeneic (self) to avoid rejection by the patients immune system. The use of allogeneic (nonself) cells carries a high risk of immune rejection and therefore requires tissue matching between donor and recipient and involves the administration of immunosuppressive drugs.
A variety of autogeneic and allogeneic cell and bioartificial tissue transplantations have been performed. Examples of autogeneic transplants using differentiated cells include blood transfusion with frozen stores of the patients own blood and repair of the articular cartilage of the knee with the patients own articular chondrocytes (cartilage cells) that have been expanded in vitro (amplified in number using cell culture techniques in a laboratory). An example of a tissue that has been generated for autogeneic transplant is the human mandible (lower jaw). Functional bioartificial mandibles are made by seeding autogeneic bone marrow cells onto a titanium mesh scaffold loaded with bovine bone matrix, a type of extracellular matrix that has proved valuable in regenerative medicine for its ability to promote cell adhesion and proliferation in transplantable bone tissues. Functional bioartificial bladders also have been successfully implanted into patients. Bioartificial bladders are made by seeding a biodegradable polyester scaffold with autogeneic urinary epithelial cells and smooth muscle cells.
Another example of a tissue used successfully in an autogeneic transplant is a bioartificial bronchus, which was generated to replace damaged tissue in a patient affected by tuberculosis. The bioartificial bronchus was constructed from an ECM scaffold of a section of bronchial tissue taken from a donor cadaver. Differentiated epithelial cells isolated from the patient and chondrocytes derived from mesenchymal stem cells collected from the patients bone marrow were seeded onto the scaffold.
There are few clinical examples of allogeneic cell and bioartificial tissue transplants. The two most common allogeneic transplants are blood-group-matched blood transfusion and bone marrow transplant. Allogeneic bone marrow transplants are often performed following high-dose chemotherapy, which is used to destroy all the cells in the hematopoietic system in order to ensure that all cancer-causing cells are killed. (The hematopoietic system is contained within the bone marrow and is responsible for generating all the cells of the blood and immune system.) This type of bone marrow transplant is associated with a high risk of graft-versus-host disease, in which the donor marrow cells attack the recipients tissues. Another type of allogeneic transplant involves the islets of Langerhans, which contain the insulin-producing cells of the body. This type of tissue can be transplanted from cadavers to patients with diabetes mellitus, but recipients require immunosuppression therapy to survive.
Cell transplant experiments with paralyzed mice, pigs, and nonhuman primates demonstrated that Schwann cells (the myelin-producing cells that insulate nerve axons) injected into acutely injured spinal cord tissue could restore about 70 percent of the tissues functional capacity, thereby partially reversing paralysis.
embryonic stem cell: scientists conducting research on embryonic stem cellsMauricio LimaAFP/Getty ImagesStudies on experimental animals are aimed at understanding ways in which autogeneic or allogeneic adult stem cells can be used to regenerate damaged cardiovascular, neural, and musculoskeletal tissues in humans. Among adult stem cells that have shown promise in this area are satellite cells, which occur in skeletal muscle fibres in animals and humans. When injected into mice affected by dystrophy, a condition characterized by the progressive degeneration of muscle tissue, satellite cells stimulate the regeneration of normal muscle fibres. Ulcerative colitis in mice was treated successfully with intestinal organoids (organlike tissues) derived from adult stem cells of the large intestine. When introduced into the colon, the organoids attached to damaged tissue and generated a normal-appearing intestinal lining.
In many cases, however, adult stem cells such as satellite cells have not been easily harvested from their native tissues, and they have been difficult to culture in the laboratory. In contrast, embryonic stem cells (ESCs) can be harvested once and cultured indefinitely. Moreover, ESCs are pluripotent, meaning that they can be directed to differentiate into any cell type, which makes them an ideal cell source for regenerative medicine.
Studies of animal ESC derivatives have demonstrated that these cells are capable of regenerating tissues of the central nervous system, heart, skeletal muscle, and pancreas. Derivatives of human ESCs used in animal models have produced similar results. For example, cardiac stem cells from heart-failure patients were engineered to express a protein (Pim-1) that promotes cell survival and proliferation. When these cells were injected into mice that had experienced myocardial infarction (heart attack), the cells were found to enhance the repair of injured heart muscle tissue. Likewise, heart muscle cells (cardiomyocytes) derived from human ESCs improved the function of injured heart muscle tissue in guinea pigs.
Derivatives of human ESCs are likely to produce similar results in humans, although these cells have not been used clinically and could be subject to immune rejection by recipients. The question of immune rejection was bypassed by the discovery in 2007 that adult somatic cells (e.g., skin and liver cells) can be converted to ESCs. This is accomplished by transfecting (infecting) the adult cells with viral vectors carrying genes that encode transcription factor proteins capable of reprogramming the adult cells into pluripotent stem cells. Examples of these factors include Oct-4 (octamer 4), Sox-2 (sex-determining region Y box 2), Klf-4 (Kruppel-like factor 4), and Nanog. Reprogrammed adult cells, known as induced pluripotent stem (iPS) cells, are potential autogeneic sources for cell transplantation and bioartificial tissue construction. Such cells have since been created from the skin cells of patients suffering from amyotrophic lateral sclerosis (ALS) and Alzheimer disease and have been used as human models for the exploration of disease mechanisms and the screening of potential new drugs. In one such model, neurons derived from human iPS cells were shown to promote recovery of stroke-damaged brain tissue in mice and rats, and, in another, cardiomyocytes derived from human iPS cells successfully integrated into damaged heart tissue following their injection into rat hearts. These successes indicated that iPS cells could serve as a cell source for tissue regeneration or bioartificial tissue construction.
Scaffolds and soluble factors, such as proteins and small molecules, have been used to induce tissue repair by undamaged cells at the site of injury. These agents protect resident fibroblasts and adult stem cells and stimulate the migration of these cells into damaged areas, where they proliferate to form new tissue. The ECMs of pig small intestine submucosa, pig and human dermis, and different types of biomimetic scaffolds are used clinically for the repair of hernias, fistulas (abnormal ducts or passageways between organs), and burns.
See the article here:
regenerative medicine | Britannica.com
- American Osteopathic Association of Prolotherapy ... - May 7th, 2016
- Organogenesis.com - Science - Regenerative Medicine - May 7th, 2016
- IRM at UPenn - Institute For Regenerative Medicine - Phila - May 7th, 2016
- Regenerative Medicine - October 10th, 2015
- Regenerative Medicine - Biolife Solutions, Inc. - October 8th, 2015
- Tissue Engineering and Regenerative Medicine | National ... - October 1st, 2015
- Regenerative Medicine - Transplant Center - Mayo Clinic - October 1st, 2015
- Regenerative Medicine - Colorado Clinic - September 27th, 2015
- MetroMD - September 24th, 2015
- Biologic Healing Regenerative Medicine - July 24th, 2015
- About Regenerative Medicine Research at the Texas Heart ... - July 17th, 2015
- Regenerative Medicine Journals | Stem Cell Articles List - July 6th, 2015
- 2015 Cluster for Regenerative Medicine Symposium - July 4th, 2015
- Wake Forest Institute for Regenerative Medicine - Official Site - July 1st, 2015
- RegenerativeMedicine.net - What is regenerative medicine? - July 1st, 2015
- Regenerative medicine - Wikipedia, the free encyclopedia - June 22nd, 2015
- Stem Cells, Regenerative Medicine, and Tissue Engineering - June 1st, 2015
- About Regenerative Medicine - Mayo Clinic - May 23rd, 2015
- Regenerative Medicine at the McGowan Institute - May 19th, 2015
- Meet the Researcher: David Lott, M.D. - Video - May 5th, 2015
- Download The California Institute for Regenerative Medicine PDF - Video - May 5th, 2015
- Download Cord Blood Stem Cells and Regenerative Medicine PDF - Video - May 5th, 2015
- PRP from Queenstown Regenerative Medicine helps Ice Blacks Captain - Video - May 2nd, 2015
- Dr. Reuben Gobezie on regenerative medicine - Video - May 2nd, 2015
- Download Strategies in Regenerative Medicine Integrating Biology with Materials Design PDF - Video - May 1st, 2015
- Dr. David Haas talks about using what's available. - Video - April 28th, 2015
- Mayo Clinic Using Regenerative Medicine to Find Answers for Hypoplastic Left Heart Syndrome - Video - April 27th, 2015
- Dr. David Haas talks about holistic medicine - Video - April 27th, 2015
- Researchers find that brain activity promotes the growth of brain cancer - Video - April 26th, 2015
- Mayo Clinic Transplant Center Regenerative Medicine Consult Service - Video - April 25th, 2015
- Global Regenerative Medicine Partnering 2010-2015 - Video - April 20th, 2015
- SIRM - Swiss Institute for Regenerative Medicine - Video - April 20th, 2015
- Innovation and research in regenerative medicine. - Video - April 20th, 2015
- Expo-Science 2015: Regenerative Medicine - Video - April 20th, 2015
- Translational Regenerative Medicine Market 2015-2025 Report - Video - April 17th, 2015
- The Regenerative Medicine Biotrust for Storing Cells - Mayo Clinic - Video - April 17th, 2015
- Histogenics - Video - April 11th, 2015
- Capricor Therapeutics - Video - April 11th, 2015
- Asterias Biotherapeutics - Video - April 11th, 2015
- AGTC - Video - April 11th, 2015
- Cellular Biomedicine Group - Video - April 11th, 2015
- ViaCyte - Video - April 11th, 2015
- Voyager Therapeutics - Video - April 11th, 2015
- Welcome Remarks - Video - April 11th, 2015
- Bone Therapeutics - Video - April 11th, 2015
- NexImmune - Video - April 11th, 2015
- ReNeuron - Video - April 11th, 2015
- Regenerative Medicine (FIXED) [4.7.15 REUPLOAD] - Video - April 11th, 2015
- TxCell - Video - April 11th, 2015
- Nadia Rosenthal: Stanford Childx Conference - Video - April 11th, 2015
- The Prolotherapist: Fox 4 Morning Blend. April 7, 2015 - Video - April 8th, 2015
- Inovio Pharmaceuticals - Video - April 4th, 2015
- No. 907 - Pharmakustik - Regenerative Medicine - Video - April 2nd, 2015
- When do you see results from this therapy? - Video - April 2nd, 2015
- No. 907 - Pharmakustik - Regenerative Medicine (Material Object Remix) - Video - April 2nd, 2015
- Golf Icon seeks new Regenerative Medicine treatment in Toledo - Video - April 2nd, 2015
- Testimonial John Edwards - Video - March 31st, 2015
- Treatment of hip tendinitis and bursitis - Video - March 31st, 2015
- Jason Wertheim Bioengineered Kidney and Future of Regenerative Medicine - Video - March 31st, 2015
- The amazing Dr. John Apsley, expert in Regenerative Medicine! - Video - March 31st, 2015
- What is Regenerative medicine in orthopedics - Video - March 31st, 2015
- James Yoo en II Congreso de Terapia Celular - Video - March 28th, 2015
- GARM Promo 2 - Video - March 25th, 2015
- Kim Solez Bridge Between Transplantation and Regenerative Medicine - Video - March 25th, 2015
- WSCS 2014: DATA ANALYSIS NEEDS IN REGENERATIVE MEDICINE (SUPPORTED BY BIOSCIENCE TECHNOLOGY) - Video - March 22nd, 2015
- The Prolotherapist: Fox Morning Blend, March 10, 2015 - Video - March 21st, 2015
- David Kekich - Regenerative Medicine (Part 3/6) - Video - March 21st, 2015
- What types of conditions does regenerative medicine treat? - Video - March 21st, 2015
- Foot and Ankle Injuries Treated with Prolotherapy - Video - March 19th, 2015
- Tennis Injuries Treated with Prolotherapy - Video - March 19th, 2015
- Laurel Barchas: Becoming a Stem Cel Scientist - Video - March 19th, 2015
- Mayo Clinic Sports Medicine Center, Mayo Clinic Square Profile - Video - March 19th, 2015
- Fox Morning Blend - The Prolotherapist March 17, 2015 - Video - March 19th, 2015
- The Ethics of Stem Cells - Video - March 17th, 2015
- Dr. Nathan Newman - Stem Cell Therapy and Regenerative Medicine - Video - March 17th, 2015
- Kansas Regenerative Medicine - Video - March 12th, 2015
- WSCS 2014: DEVELOPMENT OF JAPANESE REGENERATIVE MEDICINE INDUSTRY - Video - March 12th, 2015
- New Science of Anti Aging and Regenerative Medicine Robert Goldman, MD, PhD, FAASP, DO, FAOASM - Video - March 11th, 2015
- P-SPAN #411: "Treating Blindness with Stem Cells" - Video - March 7th, 2015
- WSCS 2014: REGENERATIVE MEDICINE FOR AGING: MAKING REJUVENATION COMPREHENSIVE NOT COSMETIC - Video - March 7th, 2015